Ajanta Pharma posts Q1 FY25 consolidated PAT at Rs. 245.77 Cr
News

Ajanta Pharma posts Q1 FY25 consolidated PAT at Rs. 245.77 Cr

Ajanta Pharma has reported total income of Rs. 1,171.39 crores during the period ended June 30, 2024

  • By IPP Bureau | August 01, 2024

Ajanta Pharma Limited has reported consolidated financial results for the period ended June 30, 2024.

Ajanta Pharma has posted net profit of Rs. 245.77 crores for the period ended June 30, 2024 as against net profit of Rs. 202.72 crores for the period ended March 31, 2024. The company posted net profit of Rs. 208.12 crores for the period ended June 30, 2023.

Ajanta Pharma has reported total income of Rs. 1,171.39 crores during the period ended June 30, 2024 as compared to Rs. 1,089.58 crores during the period ended March 31, 2024. The company s reported total income of Rs. 1,052.79 crores during the period ended June 30, 2023.

Upcoming E-conference

Other Related stories

Startup

Digitization